291 related articles for article (PubMed ID: 34577150)
21. New Designs for Phototherapeutic Transition Metal Complexes.
Imberti C; Zhang P; Huang H; Sadler PJ
Angew Chem Int Ed Engl; 2020 Jan; 59(1):61-73. PubMed ID: 31310436
[TBL] [Abstract][Full Text] [Related]
22. Unravelling the role of [Ru(bpy)
Paul L; Enkhbold K; Robinson S; Aye TT; Chung Y; Harrison DP; Pollock JA; Norris MR
J Inorg Biochem; 2022 Oct; 235():111930. PubMed ID: 35841722
[TBL] [Abstract][Full Text] [Related]
23. Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.
Papish ET; Oladipupo OE
Curr Opin Chem Biol; 2022 Jun; 68():102143. PubMed ID: 35483128
[TBL] [Abstract][Full Text] [Related]
24. Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights.
Marras E; Balacchi CJ; Orlandi V; Caruso E; Brivio MF; Bolognese F; Mastore M; Malacarne MC; Rossi M; Caruso F; Vivona V; Ferrario N; Gariboldi MB
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005258
[TBL] [Abstract][Full Text] [Related]
25. Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.
Li A; Turro C; Kodanko JJ
Acc Chem Res; 2018 Jun; 51(6):1415-1421. PubMed ID: 29870227
[TBL] [Abstract][Full Text] [Related]
26. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
27. New Ru(II) complexes for dual photoreactivity: ligand exchange and (1)O2 generation.
Knoll JD; Albani BA; Turro C
Acc Chem Res; 2015 Aug; 48(8):2280-7. PubMed ID: 26186416
[TBL] [Abstract][Full Text] [Related]
28. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
29. Ruthenium(II) Polypyridyl Complexes and Metronidazole Derivatives: A Powerful Combination in the Design of Photoresponsive Antibacterial Agents Effective under Hypoxic Conditions.
Giacomazzo GE; Conti L; Fagorzi C; Pagliai M; Andreini C; Guerri A; Perito B; Mengoni A; Valtancoli B; Giorgi C
Inorg Chem; 2023 May; 62(20):7716-7727. PubMed ID: 37163381
[TBL] [Abstract][Full Text] [Related]
30. Preparation, stability, and photoreactivity of thiolato ruthenium polypyridyl complexes: Can cysteine derivatives protect ruthenium-based anticancer complexes?
van Rixel VH; Busemann A; Göttle AJ; Bonnet S
J Inorg Biochem; 2015 Sep; 150():174-81. PubMed ID: 26187140
[TBL] [Abstract][Full Text] [Related]
31. A Lock-and-Kill Anticancer Photoactivated Chemotherapy Agent
van Geest EP; Götzfried SK; Klein DM; Salitra N; Popal S; Husiev Y; Van der Griend CJ; Zhou X; Siegler MA; Schneider GF; Bonnet S
Photochem Photobiol; 2023 Mar; 99(2):777-786. PubMed ID: 36315051
[TBL] [Abstract][Full Text] [Related]
32. Ru(II)-Complex-Based DNA Photocleaver Having Intense Absorption in the Phototherapeutic Window.
Zhang Y; Zhou Q; Tian N; Li C; Wang X
Inorg Chem; 2017 Feb; 56(4):1865-1873. PubMed ID: 28128927
[TBL] [Abstract][Full Text] [Related]
33. Photoinduced ligand exchange and DNA binding of cis-[Ru(phpy)(phen)(CH3CN)2]+ with long wavelength visible light.
Sears RB; Joyce LE; Ojaimi M; Gallucci JC; Thummel RP; Turro C
J Inorg Biochem; 2013 Apr; 121():77-87. PubMed ID: 23353083
[TBL] [Abstract][Full Text] [Related]
34. Photochemistry of Heteroleptic 1,4,5,8-Tetraazaphenanthrene- and Bi-1,2,3-triazolyl-Containing Ruthenium(II) Complexes.
Boota RZ; Hardman SJO; Ashton GP; Rice CR; Scattergood PA; Elliott PIP
Inorg Chem; 2021 Oct; 60(20):15768-15781. PubMed ID: 34612633
[TBL] [Abstract][Full Text] [Related]
35. Light Triggers the Antiproliferative Activity of Naphthalimide-Conjugated (η
Bisceglie F; Pelosi G; Orsoni N; Pioli M; Carcelli M; Pelagatti P; Pinelli S; Sadler PJ
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886972
[TBL] [Abstract][Full Text] [Related]
36. Ruthenium(II) complexes of saccharin with dipyridoquinoxaline and dipyridophenazine: Structures, biological interactions and photoinduced DNA damage activity.
Kumar P; Dasari S; Patra AK
Eur J Med Chem; 2017 Aug; 136():52-62. PubMed ID: 28482217
[TBL] [Abstract][Full Text] [Related]
37. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.
Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H
Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287
[TBL] [Abstract][Full Text] [Related]
38. A Multi-action and Multi-target Ru
Karges J; Yempala T; Tharaud M; Gibson D; Gasser G
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379
[TBL] [Abstract][Full Text] [Related]
39. Recent Approaches towards the Development of Ru(II) Polypyridyl Complexes for Anticancer Photodynamic Therapy.
Gandioso A; Purkait K; Gasser G
Chimia (Aarau); 2021 Oct; 75(10):845-855. PubMed ID: 34728011
[TBL] [Abstract][Full Text] [Related]
40. A photoactivatable chemotherapeutic Ru(II) complex bearing bathocuproine ligand efficiently induces cell death in human malignant melanoma cells through a multi-mechanistic pathway.
Elias MG; Mehanna S; Elias E; Khnayzer RS; Daher CF
Chem Biol Interact; 2021 Oct; 348():109644. PubMed ID: 34508709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
